Annovis Bio Inc.

NYSE: ANVS · Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT

Annovis Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-6.27M -6.28M -6.74M -4.39M -7.76M -7.81M -10.44M -14.86M -9.76M 9.97M -3.17M -6.49M -8.75M -5.25M -5.92M -2.85M -2.53M -3.23M
Interest Income
191.4K 187.61K 126.27K 135.43K 25.98K 44.17K 66.13K 146.66K 222.58K 232.53K 74.15K 52.89K 36.02K 19.65K 5.45K 5.55K n/a n/a
Pretax Income
-6.22M -5.54M -5.87M -12.64M -5.02M -1.07M -22.21M -14.72M -9.54M -9.74M -3.1M -7.62M -8.72M -5.23M -5.92M -2.85M -2.52M -3.2M
Net Income
-6.22M -5.54M -5.87M -12.64M -5.02M -1.07M -22.21M -14.72M -9.54M -9.74M -3.02M -7.52M -8.65M -5.23M -5.92M -2.85M -2.52M -3.2M
Selling & General & Admin
1.11M 1.27B 1.74M 1.7M 1.98M 1.29M 1.54M 1.03M 1.5M 2.18M 1.59M 2.36M 1.94M 3.1M 3.04M 1.47M 709.65K 839.63K
Research & Development
5.16M 5.01B 5M 2.69M 5.79M 6.51M 8.9M 13.84M 8.26M 7.79M 1.58M 5.31M 6.82M 2.81M 2.88M 1.38M 1.82M 2.39M
Other Expenses
n/a -6.28B n/a n/a 579.00 n/a -1K -1K n/a n/a n/a n/a n/a n/a n/a n/a -7.41K n/a
Operating Expenses
6.27M 6.28M 6.74M 4.39M 7.76M 7.81M 10.44M 14.86M 9.76M 9.97M 3.17M 6.49M 8.75M 5.25M 5.92M 2.85M 2.53M 3.2M
Interest Expense
n/a n/a n/a 524.07K 1.35M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.13K 197.00
Selling & Marketing Expenses
n/a n/a n/a -1.7B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.27M 6.28M 6.74M 4.39M 7.76M 7.81M 10.44M 14.86M 9.76M 9.97M 3.17M 6.49M 8.75M -5.25M 5.92M 2.85M 2.53M 3.2M
Income Tax Expense
n/a n/a -5 n/a n/a 3.00 -10.44K n/a -9.76K 19.71M -74.15K -106K -72.05K -39.3K -10.9K n/a n/a n/a
Shares Outstanding (Basic)
19.49M 12.18M 13.79M 12.98M 11.31M 10.63M 9.53M 9.01M 8.95M 8.2M 8.16M 8.16M 8.16M 8.16M 8.1M 8.1M 7.37M 6.92M
Shares Outstanding (Diluted)
19.49M 12.23M 13.79M 12.98M 11.31M 10.63M 9.53M 9.01M 8.95M 8.2M 8.16M 8.16M 8.16M 8.16M 8.1M 8.1M 7.37M 6.92M
EPS (Basic)
-0.32 -0.32 -0.43 -0.97 -0.44 -0.1 -2.33 -1.63 -1.07 -3.59 -0.37 -0.79 -1.06 -0.72 -0.73 -0.35 -0.34 -0.46
EPS (Diluted)
-0.32 -0.45 -0.48 -0.97 -0.44 -0.1 -2.33 -1.63 -1.07 -3.59 -0.37 -0.92 -1.06 -0.72 -0.73 -0.35 -0.34 -0.46
EBITDA
-6.22M -6.28M -6.74M -4.39M -7.76M -7.81M -10.44M -14.86M -9.76M -9.97M -3.17M -6.49M -5.97M -5.25M -5.92M -2.85M -2.53M -3.2M
EBIT
-6.22M -6.28M -6.74M -4.39M -7.76M -7.81M -10.44M -14.86M -9.54M -9.74M -7.8M -7.62M -8.72M -5.25M -5.92M -2.85M -2.53M -3.2M
Depreciation & Amortization
n/a n/a 5.00 n/a n/a -3 4.00 14.86M 9.76M 9.97M 7.8M 6.49M 5.97M 5.25M 5.92M 2.85M 2.53M 3.23M